{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:53:50Z","timestamp":1791060830122,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,2,1]],"date-time":"2027-02-01T00:00:00Z","timestamp":1801440000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M711719"],"award-info":[{"award-number":["2022M711719"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016806","name":"Natural Science Foundation of Nantong Municipality","doi-asserted-by":"publisher","award":["JC2025021"],"award-info":[{"award-number":["JC2025021"]}],"id":[{"id":"10.13039\/100016806","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tissue and Cell"],"published-print":{"date-parts":[[2027,2]]},"DOI":"10.1016\/j.tice.2026.103960","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:22:05Z","timestamp":1789665725000},"page":"103960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"P2","title":["Integrin beta-like 1 protects against liver injury by inhibiting ferroptosis in metabolic dysfunction-associated steatohepatitis"],"prefix":"10.1016","volume":"104","author":[{"given":"Wen","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-Qi","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Fei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui-Hua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Xiu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8471-530X","authenticated-orcid":false,"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tice.2026.103960_bib1","doi-asserted-by":"crossref","DOI":"10.7326\/ANNALS-24-02933","article-title":"Metabolic dysfunction-associated steatotic liver disease","volume":"178","author":"Ali","year":"2025","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tice.2026.103960_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/geno.1998.5707","article-title":"Cloning and characterization of a novel beta integrin-related cDNA coding for the protein TIED (\"ten beta integrin EGF-like repeat domains\") that maps to chromosome band 13q33: a divergent stand-alone integrin stalk structure","volume":"56","author":"Berg","year":"1999","journal-title":"Genomics"},{"key":"10.1016\/j.tice.2026.103960_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12943-020-01306-2","article-title":"ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicity","volume":"20","author":"Cheli","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tice.2026.103960_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12092676","article-title":"Evaluation of the Role of ITGBL1 in Ovarian Cancer","volume":"12","author":"Cortez","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.tice.2026.103960_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nchembio.2239","article-title":"ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition","volume":"13","author":"Doll","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.tice.2026.103960_bib6","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","author":"EASL-EASD-EASO","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tice.2026.103960_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with Liver Fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tice.2026.103960_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12836","article-title":"ITGBL1 promotes cell migration and invasion through stimulating the TGF-\u03b2 signalling pathway in hepatocellular carcinoma","volume":"53","author":"Huang","year":"2020","journal-title":"Cell. Prolif."},{"key":"10.1016\/j.tice.2026.103960_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.tice.2026.103960_bib10","doi-asserted-by":"crossref","first-page":"C1637","DOI":"10.1152\/ajpcell.00951.2024","article-title":"Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease","volume":"328","author":"Kuchay","year":"2025","journal-title":"Am. J. Physiol. Cell. Physiol."},{"key":"10.1016\/j.tice.2026.103960_bib11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jhep.2008.03.026","article-title":"MCD-induced steatohepatitis is associated with hepatic adiponectin resistance and adipogenic transformation of hepatocytes","volume":"49","author":"Larter","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tice.2026.103960_bib12","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1158\/0008-5472.CAN-15-0240","article-title":"ITGBL1 Is a Runx2 transcriptional target and promotes breast cancer bone metastasis by activating the TGF\u03b2 signaling pathway","volume":"75","author":"Li","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.tice.2026.103960_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/JCI203412","article-title":"ITGBL1-MYH9 interaction in hepatic stellate cells acts as a mechano-regulator controlling liver fibrosis in mice","author":"Li","year":"2026","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.tice.2026.103960_bib14","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1007\/s00109-025-02599-w","article-title":"Involvement of ferroptosis in metabolic dysfunction-associated steatohepatitis-related liver diseases","volume":"103","author":"Liu","year":"2025","journal-title":"J. Mol. Med. (Berl. )"},{"key":"10.1016\/j.tice.2026.103960_bib15","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s12253-015-9946-3","article-title":"Ferroptosis is involved in acetaminophen induced cell death","volume":"21","author":"L\u0151rincz","year":"2015","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.tice.2026.103960_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12943-019-0945-y","article-title":"Transcriptomic expression profiling identifies ITGBL1, an epithelial to mesenchymal transition (EMT)-associated gene, is a promising recurrence prediction biomarker in colorectal cancer","volume":"18","author":"Matsuyama","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.tice.2026.103960_bib17","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0140-6736(25)02276-7","article-title":"Efimosfermin alfa (BOS-580) once per month in people with metabolic dysfunction-associated steatohepatitis with F2 or F3 fibrosis: results from a 24-week, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"407","author":"Noureddin","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.tice.2026.103960_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.33160\/yam.2025.05.002","article-title":"Selective PPAR\u03b1 Modulator (SPPARM\u03b1) in the Era of the MASLD Pandemic: Current Insights and Future Prospects","volume":"68","author":"Sugihara","year":"2025","journal-title":"Yonago Acta Med."},{"key":"10.1016\/j.tice.2026.103960_bib19","doi-asserted-by":"crossref","first-page":"11175","DOI":"10.1073\/pnas.201420198","article-title":"Definition of EGF-like, closely interacting modules that bear activation epitopes in integrin beta subunits","volume":"98","author":"Takagi","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.tice.2026.103960_bib20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/s41419-019-1678-y","article-title":"Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis","volume":"10","author":"Tsurusaki","year":"2019","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.tice.2026.103960_bib21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.tem.2026.01.007","article-title":"Targeting ferroptosis to halt MASLD and MASH","volume":"37","author":"Wang","year":"2026","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.tice.2026.103960_bib22","article-title":"Characterization of gene expression profiles in HBV-related liver fibrosis patients and identification of ITGBL1 as a key regulator of fibrogenesis","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tice.2026.103960_bib23","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.tice.2026.103960_bib24","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/JHC.S306966","article-title":"Serum levels of ITGBL1 as an early diagnostic biomarker for hepatocellular carcinoma with hepatitis b virus infection","volume":"8","author":"Ye","year":"2021","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.tice.2026.103960_bib25","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41420-021-00768-7","article-title":"Berberine alleviates liver fibrosis through inducing ferrous redox to activate ROS-mediated hepatic stellate cells ferroptosis","volume":"7","author":"Yi","year":"2021","journal-title":"Cell. Death Discov."}],"container-title":["Tissue and Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626006555?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040816626006555?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T20:08:55Z","timestamp":1791058135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040816626006555"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,2]]},"references-count":25,"alternative-id":["S0040816626006555"],"URL":"https:\/\/doi.org\/10.1016\/j.tice.2026.103960","relation":{},"ISSN":["0040-8166"],"issn-type":[{"value":"0040-8166","type":"print"}],"subject":[],"published":{"date-parts":[[2027,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrin beta-like 1 protects against liver injury by inhibiting ferroptosis in metabolic dysfunction-associated steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Tissue and Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tice.2026.103960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103960"}}